Description
Eribulin Mesylate, supplied generically under the brand Ebunat, is a microtubule inhibitor used for the treatment of patients with:
- Metastatic breast cancer who have previously been treated with at least two chemotherapeutic regimens for their metastatic disease. Before starting this therapy, patients should have already received a type of chemotherapy called an anthracycline and another type called a taxane.
- Unresectable or metastatic liposarcoma who have previously been treated with an anthracycline-containing regimen.Â
Dosage and Side Effects: The recommended dosage of Eribulin Mesylate is 1.4 mg per square meter of body surface administered intravenously (IV) over 2-5 minutes on Days 1 and 8 of a 21-day cycle. Reduce the dose of Eribulin in patients with hepatic impairment or with moderate or severe renal impairment. It is not advisable to mix it with other medicines or administer it with dextrose-containing solutions.Â
The most common side effects of Eribulin Mesylate in metastatic breast cancer are anemia, neutropenia, nausea, fatigue, peripheral neuropathy, alopecia, and constipation.
The most common side effects of Eribulin Mesylate in liposarcoma and leiomyosarcoma are constipation, fatigue, nausea, alopecia, abdominal pain, peripheral neuropathy, and pyrexia.
Warning and Precautions:
- Patients with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) >3 x upper limit of normal (ULN) experienced an increased incidence of Grade 4 neutropenia and febrile neutropenia. Monitor complete blood counts (CBC) before each dose; increase the frequency of monitoring in those who develop Grade 3/4 cytopenias.
- Peripheral neuropathy may develop in patients with metastatic breast cancer (MBC) receiving treatment with Eribulin. Monitor patients precisely for signs of peripheral motor and sensory neuropathy. Withhold Eribulin in those who experience Grade 3/4 peripheral neuropathy, until resolution to Grade 2 or less.
- Findings and mechanism of action suggest that Eribulin 1 mg per 2 mL (0.5 mg per mL) can cause fetal harm if administered to a pregnant woman. Women who could become pregnant should use birth control during treatment and for 2 weeks after the last dose.
- QT prolongation may occur. ECG monitoring is required if therapy is initiated in individuals with congestive heart failure, bradyarrhythmias, or drugs known to prolong the QT interval. Correct hypokalemia or hypomagnesemia before initiating Eribulin and monitor these electrolytes periodically during therapy. Avoid the use of Eribulin in those with congenital long QT syndrome.
FAQ's
What is Eribulin Mesylate?
Eribulin Mesylate is sold under the generic brand Ebunat for the treatment and management of patients with metastatic breast cancer and unresectable or metastatic liposarcoma.
How can Eribulin Mesylate be administered?Â
Eribulin Mesylate is usually administered as an intravenous (IV) infusion by a healthcare professional in a medical setting.
How can I store Eribulin Mesylate?
Store Eribulin Mesylate at room temperature, away from light and moisture, and out of reach of children and pets.
How much does Eribulin Mesylate cost in India?
Eribulin Mesylate cost in India is reasonable and can vary. To procure this medicine legally, you can call us at (+91) 8130290915, TOLL-FREE: 1800-889-1064, Or Write us at info@indiangenericmedicines.com.
Can Eribulin Mesylate be used while breastfeeding?
Breastfeeding is not recommended while on Eribulin Mesylate. Talk to your healthcare provider (HCP) in case you are breastfeeding or want to breastfeed.
Where can I get Eribulin Mesylate at the best Price?Â
Order Eribulin at the best price today. We request you to Call/WhatsApp us at (+91) 8130290915 or dial our TOLL-FREE Number: 1800-889-1064 or Write us at info@indiangenericmedicines.com. We are fully committed to providing you with the best Eribulin Mesylate price from India. That is why we’ll match the cost/price of any other existing suppliers/distributors in the market who require a medical prescription.
Is the Eribulin Mesylate available in India?
Eribulin is a (prescription drug, doctor-prescribed medication, or health care professional-prescribed medicine) pharmaceutical drug that can be legally dispensed against a medical prescription. Eribulin Mesylate can be made available through the network of authorized distributors in India. (Bangalore, Mumbai, Chennai, Ahmedabad, Kolkata, Hyderabad, Delhi, Pune, etc.).Â
Can You Send the Eribulin to Foreign Destinations?
Buy generic Eribulin online at the best/lowest price from a leading supplier. Indian Generic Medicines can assist in the delivery of Eribulin; the doctor-prescribed medicine to the UK, Canada, Australia, UAE, Philippines, the USA, Saudi Arabia, Thailand, China, South Africa, Kazakhstan, Uzbekistan, Afghanistan, Qatar, Japan, Zambia, Pakistan, Kuwait, Sweden, Hong Kong, Turkey, Malaysia, Singapore, Nepal, Sri Lanka, and many other countries.
What is the procedure to buy Eribulin from Indian Generic Medicines?Â
Patients can fill out the order form or send mail to info@indiangenericmedicines.com. Patients can also send WhatsApp messages to +91 8130290915 or can dial the TOLL-FREE Number: 18008891064. We will reply ASAP with the details of the Eribulin 0.5 mg/mL price and the procurement procedure.
Note:- The order will be confirmed only after the valid receipt of the prescription from the Physician.
Is it safe to buy Eribulin Mesylate online from India?
Yes, one can buy Eribulin online from India-based Indian Generic Medicines if the medicine is not (yet) registered or is unavailable in their respective country. We can facilitate the supply of Eribulin Mesylate through legal channels.
